Web Results

Merck Drug Patents Asserted Against Gilead Valid, Jury Finds ...

www.law360.com/articles/775066/merck-drug-patents-asserted-against-gilead-valid-jury-finds

Mar 22, 2016 ... The case is Gilead Sciences Inc. v. Merck & Co. Inc. et al., case number 5:13-cv- 04057, in the U.S. District Court for the Northern District of ...

Mayne Pharma International Pty Ltd. v. Merck & Co., Inc., et al

www.law360.com/cases/5568be209570fc5b68000001

Parties, docket activity and news coverage of federal case Mayne Pharma International Pty Ltd. v. Merck & Co., Inc., et al, case number 1:15-cv-00438, from  ...

b-tS-\I - Probe International

probeinternational.org/library/wp-content/uploads/2014/09/chatom-v-merck.pdf

(Prisoner P e t ~ t ~ o n ) .... NOE~. 3. Does this case involve the validity or infringement of a patent already in suit or any earlier numbered case pending or within one year ... JURY TRIAL DEMANDED. 1 v. 1. Electronically Filed. 1. MERCK & CO., INC.,. 1 .... Plaintiff Chatom Primary, Care P.C. is an Alabama corporation.

Therapeutic potential of neuropeptide Y (NPY) receptor ligands - NCBI

www.ncbi.nlm.nih.gov/pmc/articles/PMC3394504/

On the other hand, Y1R knockout mice (Kushi et al, 1998) have higher body weights and .... viral vectors in rat hippocampi (Noe et al, 2009, 2010; Sperk et al, 2007). ..... MK-0557 (Merck & Co., Inc.) and S-2367 (velneperit, Shionogi & Co, Ltd). ..... [PubMed]; Tatemoto K, Carlquist M, Mutt V. Neuropeptide Y—a novel brain ...

Trial Activity | Colvin, Chaney, Saenz, & Rodriguez, L.L.P. ...

www.rcclaw.com/trial-activity/

National Lloyds Insurance Company, et al., Cause No. ... Court of Hidalgo County , Texas; Judge Noe Gonzalez presiding. Zellers v. City of McAllen, Cause No.

771. Ivermectin (WHO Food Additives Series 31) - ipcs inchem

www.inchem.org/documents/jecfa/jecmono/v31je03.htm

2.2 Toxicological Studies 2.2.1 Comparative toxicity: CF1 mouse vs rat and rabbit The ... 0.4 0.4 2.0<sup>a</sup> 3.0 3.0 10.0 NOE = no-observed-effect level in mg/kg bw per day. ... All the animals given ivermectin subcutaneously recovered (Merck & Co. .... in humans have failed to reproduce this effect (Hay et al., 1990; Richards et al.,  ...

Intellectual Property Proceedings in Federal Court for 2009 | IPPractice

www.ippractice.ca/litigation-statistics/intellectual-property-proceedings-in-federal-court-for-2009/

T-170-09, MERCK & CO., INC. ET AL v. THE MINISTER OF HEALTH ET AL ... ET AL v. OSIRIS, INC. Patent Infringement, 2009-02-25, Moffat & Co., Macera ...

Table of cases - Manual of Patent Practice - Guidance - GOV.UK

www.gov.uk/guidance/manual-of-patent-practice-mopp/table-of-cases

Notes: For EPO decisions, see separate list below.

Aggrecanase and metalloproteinase-specific aggrecan neo ...

www.sciencedirect.com/science/article/pii/S1063458497800453

RIII wt mice with CIA exhibited either one or the other 412 Singer et al. ... Both the 'aggrecanase' and MMP neo-epitopes may be co-distributed in the AC of B10. .... MN, U.S.A.) for their help in establishing the CIA mouse model at Merck Research .... Moore V. A matrix metalloproteinase-generated aggrecan neoepitope as a ...

A Quantitative Volumetric Micro-Computed Tomography Method to ...

www.sciencedirect.com/science/article/pii/S1476558609800870

E-mail: weisheng_zhang@merck.com; or Cyrille Sur, Imaging Department, Merck ... Press, Inc. All rights reserved 1522-8002/09/$25.00 DOI 10.1593/neo.81030 .... The average of T & V volume in KP and K mice infected with the high dose of ..... Li AR, Patel JD, Heelan RT, Kris MG, Sandler AB, Carbone DP, Tsao A, et al.

More Info

North Sound Capital LLC, et al v. Merck & Co Inc, et al - Law360

www.law360.com

Jul 12, 2016 ... Parties, docket activity and news coverage of federal case North Sound Capital LLC, et al v. Merck & Co Inc, et al, case number 16-1367, from ...

SEC.gov | Commission Legal Briefs Index

www.sec.gov

May 31, 2016 ... Neo@Ogilvy LLC and WPP Group USA, Inc., and Liu Meng-Lin v. Siemens AG) ... Digital Realty Trust Inc.), addressing Commission Rule 21F-2(b)(1), 17 C.F.R. ... 2014, Halliburton Co. v. .... Oct. 2009, Merck & Co., Inc., et al. v.

Integrated systems approach identifies genetic nodes and networks ...

www.ncbi.nlm.nih.gov

Apr 25, 2013 ... As observed in previous network-based studies (Chen et al., 2008; Emilsson et al . ... et al., 2011); (4) The postsynaptic density proteome in the human neo-cortex of ..... of Merck & Co., Inc. JRL is an employee and shareholder of Novartis ... Emilsson V, Thorleifsson G, Zhang B, Leonardson AS, Zink F, Zhu J, ....